vs
FLEXIBLE SOLUTIONS INTERNATIONAL INC(FSI)与礼来(RNA)财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是FLEXIBLE SOLUTIONS INTERNATIONAL INC的1.4倍($12.5M vs $9.1M),FLEXIBLE SOLUTIONS INTERNATIONAL INC净利率更高(-5.1% vs -1398.3%,领先1393.3%),礼来同比增速更快(434.0% vs -0.5%),FLEXIBLE SOLUTIONS INTERNATIONAL INC自由现金流更多($-4.0M vs $-156.9M),过去两年礼来的营收复合增速更高(138.5% vs -0.6%)
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业,核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等,服务北美及全球农业、水务领域客户。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
FSI vs RNA — 直观对比
营收规模更大
RNA
是对方的1.4倍
$9.1M
营收增速更快
RNA
高出434.6%
-0.5%
净利率更高
FSI
高出1393.3%
-1398.3%
自由现金流更多
FSI
多$152.8M
$-156.9M
两年增速更快
RNA
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $9.1M | $12.5M |
| 净利润 | $-460.9K | $-174.4M |
| 毛利率 | 29.4% | — |
| 营业利润率 | 11.6% | -1513.5% |
| 净利率 | -5.1% | -1398.3% |
| 营收同比 | -0.5% | 434.0% |
| 净利润同比 | -167.8% | -117.0% |
| 每股收益(稀释后) | $-0.03 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FSI
RNA
| Q4 25 | $9.1M | — | ||
| Q3 25 | $10.6M | $12.5M | ||
| Q2 25 | $11.4M | $3.8M | ||
| Q1 25 | $7.5M | $1.6M | ||
| Q4 24 | $9.2M | $3.0M | ||
| Q3 24 | $9.3M | $2.3M | ||
| Q2 24 | $10.5M | $2.0M | ||
| Q1 24 | $9.2M | $3.5M |
净利润
FSI
RNA
| Q4 25 | $-460.9K | — | ||
| Q3 25 | $-503.4K | $-174.4M | ||
| Q2 25 | $2.0M | $-157.3M | ||
| Q1 25 | $-277.7K | $-115.8M | ||
| Q4 24 | $679.6K | $-102.3M | ||
| Q3 24 | $611.9K | $-80.4M | ||
| Q2 24 | $1.3M | $-70.8M | ||
| Q1 24 | $457.2K | $-68.9M |
毛利率
FSI
RNA
| Q4 25 | 29.4% | — | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | 47.4% | — | ||
| Q1 25 | 26.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | 40.9% | — | ||
| Q2 24 | 37.4% | — | ||
| Q1 24 | 30.6% | — |
营业利润率
FSI
RNA
| Q4 25 | 11.6% | — | ||
| Q3 25 | 2.9% | -1513.5% | ||
| Q2 25 | 29.0% | -4448.7% | ||
| Q1 25 | -0.9% | -8360.9% | ||
| Q4 24 | 9.4% | -4069.6% | ||
| Q3 24 | 20.5% | -4200.9% | ||
| Q2 24 | 18.7% | -4040.4% | ||
| Q1 24 | 8.3% | -2178.6% |
净利率
FSI
RNA
| Q4 25 | -5.1% | — | ||
| Q3 25 | -4.8% | -1398.3% | ||
| Q2 25 | 17.8% | -4089.3% | ||
| Q1 25 | -3.7% | -7360.0% | ||
| Q4 24 | 7.4% | -3439.5% | ||
| Q3 24 | 6.6% | -3441.7% | ||
| Q2 24 | 12.3% | -3461.8% | ||
| Q1 24 | 5.0% | -1943.4% |
每股收益(稀释后)
FSI
RNA
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.04 | $-1.27 | ||
| Q2 25 | $0.15 | $-1.21 | ||
| Q1 25 | $-0.02 | $-0.90 | ||
| Q4 24 | $0.05 | $-0.80 | ||
| Q3 24 | $0.05 | $-0.65 | ||
| Q2 24 | $0.10 | $-0.65 | ||
| Q1 24 | $0.04 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $350.2M |
| 总债务越低越好 | $4.4M | — |
| 股东权益账面价值 | $38.9M | $1.9B |
| 总资产 | $61.8M | $2.1B |
| 负债/权益比越低杠杆越低 | 0.11× | — |
8季度趋势,按日历期对齐
现金及短期投资
FSI
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | $350.2M | ||
| Q2 25 | $10.0M | $243.9M | ||
| Q1 25 | $11.0M | $254.2M | ||
| Q4 24 | $10.0M | $219.9M | ||
| Q3 24 | $13.0M | $370.2M | ||
| Q2 24 | $9.2M | $575.8M | ||
| Q1 24 | $8.3M | $471.4M |
总债务
FSI
RNA
| Q4 25 | $4.4M | — | ||
| Q3 25 | $7.1M | — | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $8.1M | — | ||
| Q4 24 | $8.8M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $8.3M | — | ||
| Q1 24 | $8.0M | — |
股东权益
FSI
RNA
| Q4 25 | $38.9M | — | ||
| Q3 25 | $39.0M | $1.9B | ||
| Q2 25 | $39.4M | $1.2B | ||
| Q1 25 | $38.4M | $1.3B | ||
| Q4 24 | $38.0M | $1.4B | ||
| Q3 24 | $36.9M | $1.5B | ||
| Q2 24 | $36.2M | $1.2B | ||
| Q1 24 | $36.0M | $830.9M |
总资产
FSI
RNA
| Q4 25 | $61.8M | — | ||
| Q3 25 | $58.4M | $2.1B | ||
| Q2 25 | $58.2M | $1.4B | ||
| Q1 25 | $61.7M | $1.5B | ||
| Q4 24 | $60.0M | $1.6B | ||
| Q3 24 | $57.8M | $1.6B | ||
| Q2 24 | $56.3M | $1.3B | ||
| Q1 24 | $57.6M | $951.5M |
负债/权益比
FSI
RNA
| Q4 25 | 0.11× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.21× | — | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $-156.9M |
| 自由现金流率自由现金流/营收 | -44.3% | -1257.6% |
| 资本支出强度资本支出/营收 | 11.7% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-591.7K | $-592.3M |
8季度趋势,按日历期对齐
经营现金流
FSI
RNA
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $2.0M | $-156.2M | ||
| Q2 25 | $5.3M | $-199.7M | ||
| Q1 25 | $-544.3K | $-124.8M | ||
| Q4 24 | $-2.2M | $-99.9M | ||
| Q3 24 | $2.5M | $-65.6M | ||
| Q2 24 | $5.9M | $-65.0M | ||
| Q1 24 | $-604.8K | $-70.4M |
自由现金流
FSI
RNA
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $39.4K | $-156.9M | ||
| Q2 25 | $4.3M | $-203.0M | ||
| Q1 25 | $-898.4K | $-128.6M | ||
| Q4 24 | $-4.3M | $-103.8M | ||
| Q3 24 | $1.3M | $-67.3M | ||
| Q2 24 | $4.7M | $-65.5M | ||
| Q1 24 | $-1.1M | $-71.3M |
自由现金流率
FSI
RNA
| Q4 25 | -44.3% | — | ||
| Q3 25 | 0.4% | -1257.6% | ||
| Q2 25 | 37.9% | -5277.1% | ||
| Q1 25 | -12.0% | -8174.3% | ||
| Q4 24 | -47.0% | -3491.0% | ||
| Q3 24 | 13.6% | -2881.8% | ||
| Q2 24 | 44.9% | -3204.6% | ||
| Q1 24 | -11.7% | -2012.3% |
资本支出强度
FSI
RNA
| Q4 25 | 11.7% | — | ||
| Q3 25 | 18.7% | 5.7% | ||
| Q2 25 | 8.6% | 86.9% | ||
| Q1 25 | 4.7% | 238.6% | ||
| Q4 24 | 22.8% | 131.7% | ||
| Q3 24 | 13.0% | 72.9% | ||
| Q2 24 | 11.3% | 26.0% | ||
| Q1 24 | 5.2% | 25.8% |
现金转化率
FSI
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.60× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.27× | — | ||
| Q3 24 | 4.05× | — | ||
| Q2 24 | 4.59× | — | ||
| Q1 24 | -1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图